Literature DB >> 25340256

Poloxamer-188 and citicoline provide neuronal membrane integrity and protect membrane stability in cortical spreading depression.

Timur Yıldırım1, Alpaslan Eylen2, Sevda Lule3, Sefik Evren Erdener3,4, Atay Vural3,4, Hulya Karatas3,4, Mehmet Faik Ozveren5, Turgay Dalkara3,4, Yasemin Gursoy-Ozdemir3,4.   

Abstract

Under pathological conditions such as brain trauma, subarachnoid hemorrhage and stroke, cortical spreading depression (CSD) or peri-infarct depolarizations contribute to brain damage in animal models of neurological disorders as well as in human neurological diseases. CSD causes transient megachannel opening on the neuronal membrane, which may compromise neuronal survival under pathological conditions. Poloxamer-188 (P-188) and citicoline are neuroprotectants with membrane sealing properties. The aim of this study is to investigate the effect of P-188 and citicoline on the neuronal megachannel opening induced by CSD in the mouse brain. We have monitored megachannel opening with propidium iodide, a membrane impermeable fluorescent dye and, demonstrate that P-188 and citicoline strikingly decreased CSD-induced neuronal PI influx in cortex and hippocampal dentate gyrus. Therefore, these agents may be providing neuroprotection by blocking megachannel opening, which may be related to their membrane sealing action and warrant further investigation for treatment of traumatic brain injury and ischemic stroke.

Entities:  

Keywords:  citicoline; cortical spreading depression; megachannels; neuroprotection; poloxamer-188

Mesh:

Substances:

Year:  2014        PMID: 25340256     DOI: 10.3109/00207454.2014.979289

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

1.  Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury.

Authors:  Ye Xiong; Li Zhang; Zheng Gang Zhang; Asim Mahmood; Michael Chopp
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

Review 2.  [The role of citicoline in glaucoma].

Authors:  Anselm G M Jünemann; P Grieb; R Rejdak
Journal:  Ophthalmologe       Date:  2021-03-17       Impact factor: 1.059

3.  Multicenter, Prospective, Randomized, Single Blind, Cross-Over Study on the Effect of a Fixed Combination of Citicoline 500 mg Plus Homotaurine 50 mg on Pattern Electroretinogram (PERG) in Patients With Open Angle Glaucoma on Well Controlled Intraocular Pressure.

Authors:  Gemma Caterina Maria Rossi; Teresa Rolle; Annalisa De Silvestri; Dario Sisto; Alberto Mavilio; Alessandra Venera Mirabile; Alessia Paviglianiti; Beatrice Strano; Erica Picasso; Gian Maria Pasinetti; Giovanni Milano; Giulio Ruberto
Journal:  Front Med (Lausanne)       Date:  2022-04-29

Review 4.  Role of functional pharmacological therapy in post-stroke depression: a narrative review.

Authors:  Francesco Corallo; Chiara Scarfì; Francesca Antonia Arcadi; Caterina Formica; Marcella Di Cara; Rosanna Palmeri; Laura Romeo; Viviana Lo Buono; Placido Bramanti; Silvia Marino; Maria Cristina De Cola
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

5.  Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways.

Authors:  Shih-En Tang; Wen-I Liao; Hsin-Ping Pao; Chin-Wang Hsu; Shu-Yu Wu; Kun-Lun Huang; Shi-Jye Chu
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.